# Redalpine's Biotech Investments: 14 Startups in Its Portfolio (2026) > The 14 Biotech startups Redalpine has backed, by stage: $313M raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/redalpine-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series A 4 - [TOLREMO therapeutics](https://millionrounds.com/company/tolremo-therapeutics) - [*U* Uncommon](https://millionrounds.com/company/uncommon) - [*I* ImmunOS](https://millionrounds.com/company/immunos) - [Genialis](https://millionrounds.com/company/genialis) ## Series C and later 3 - [Lunaphore](https://millionrounds.com/company/lunaphore) - [InSphero](https://millionrounds.com/company/insphero) - [Memo Therapeutics](https://millionrounds.com/company/memo-therapeutics) ## Stage not reported 3 - [Sanity Group](https://millionrounds.com/company/sanity-group) - [aktiia](https://millionrounds.com/company/aktiia) - [Araris Biotech](https://millionrounds.com/company/araris-biotech) ## Series B 2 - [Infinite Roots](https://millionrounds.com/company/infinite-roots) - [Morressier](https://millionrounds.com/company/morressier) ## Pre-seed and seed 2 - [DaltonTx](https://millionrounds.com/company/daltontx) - [Level Zero Health](https://millionrounds.com/company/level-zero-health) ## Segment by segment ### Series A 4 startups · $97M raised - [**TOLREMO therapeutics**](https://millionrounds.com/company/tolremo-therapeutics) TOLREMO Therapeutics is a Swiss biotechnology company founded in 2017 as a spin-off from ETH Zürich. Switzerland $38M - [*U* **Uncommon**](https://millionrounds.com/company/uncommon) Uncommon designs and develops merchandise and teamwear. United Kingdom $30M - [*I* **ImmunOS**](https://millionrounds.com/company/immunos) Switzerland $15M - [**Genialis**](https://millionrounds.com/company/genialis) Genialis is a computational precision medicines company that develops a clinical biomarker discovery platform. United States $14M ### Series C and later 3 startups · $98M raised - [**Lunaphore**](https://millionrounds.com/company/lunaphore) Lunaphore is a life sciences company that is creating technologies to enable spatial biology in all laboratories. Switzerland $38M - [**InSphero**](https://millionrounds.com/company/insphero) InSphero is a supplier of organotypic, biological, in vitro 3D microtissues for highly predictive drug testing. Switzerland $35M - [**Memo Therapeutics**](https://millionrounds.com/company/memo-therapeutics) Memo Therapeutics is an innovator in the field of antibody discovery and immune repertoire analysis. Switzerland $24M ### Stage not reported 3 startups · $19M raised - [**Sanity Group**](https://millionrounds.com/company/sanity-group) Sanity Group is a cannabis company that provides cannabinoid-based pharmaceuticals and well-being products. Germany $12M - [**aktiia**](https://millionrounds.com/company/aktiia) AI-driven insights for a novel understanding and care of Hypertension Switzerland $4.4M - [**Araris Biotech**](https://millionrounds.com/company/araris-biotech) Araris Biotech is a biotechnology platform enables the attachment of any payload to ‘off the shelf’ antibodies. Switzerland $2.5M ### Series B 2 startups · $82M raised - [**Infinite Roots**](https://millionrounds.com/company/infinite-roots) Infinite Roots is a biotech company that uses mycelium, or mushroom roots, to create alternative proteins to transform the food system. Germany $61M - [**Morressier**](https://millionrounds.com/company/morressier) Morressier is your partner in early-stage and conference research, extending the value of your event long after it’s over. Germany $21M ### Pre-seed and seed 2 startups · $18M raised - [**DaltonTx**](https://millionrounds.com/company/daltontx) DaltonTx is a UK-based biotechnology and healthcare IT company founded in 2024. United Kingdom $11M - [**Level Zero Health**](https://millionrounds.com/company/level-zero-health) Building cutting-edge biosensor technology. United Kingdom $6.9M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Redalpine as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Redalpine's AI portfolio** 16 startups · $701M](https://millionrounds.com/portfolio-maps/redalpine-ai-portfolio)[Portfolio map **Redalpine portfolio map** 46 startups · $1.6B](https://millionrounds.com/portfolio-maps/redalpine-portfolio-map)[Co-investors **Who invests with Redalpine** 35 co-investors](https://millionrounds.com/portfolio-maps/redalpine-co-investors)[Sector portfolio **Novartis' Biotech portfolio** 51 startups · $5.4B](https://millionrounds.com/portfolio-maps/novartis-biotech-portfolio)[Sector portfolio **Lakestar's AI portfolio** 26 startups · $4.6B](https://millionrounds.com/portfolio-maps/lakestar-ai-portfolio)[Sector portfolio **Lakestar's Fintech portfolio** 20 startups · $7.3B](https://millionrounds.com/portfolio-maps/lakestar-fintech-portfolio) ## Raising from investors like Redalpine? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)